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Crystal formation in kidney tissue is increasingly recognized as a major cause of severe or
acute renal failure. Kidney biopsies are currently performed and analyzed using different
staining procedures. Unfortunately, none of these techniques are able to distinguish the
different Ca phosphates (e.g., amorphous or nanostructured Ca phosphate apatite, octa-
calcium phosphate, brushite…) or Ca oxalates (whewellite and weddellite). Moreover, the
crystal’s morphology, a structural parameter proven as a major information to the clinician
regarding kidney stones, is not taken into account. Such major limitations call for a
different research approach, based on physicochemical techniques. Here we propose
classical observations through ﬁeld-emission scanning electron microscopy experiments
combined with energy dispersive spectroscopy as well as measurements through Raman
and mFourier transform Infra-Red Spectroscopy. If necessary, in the case of microcrystals,
observations using cutting edge technology such as Synchrotron Radiation (SR) e FTIR or
SR-UV visible spectroscopy can be subsequently performed on the same sample. Taken
together this set of diagnostic tools will help clinicians gather information regarding the
nature and the spatial distribution at the subcellular scale of different chemical phases
present in kidney biopsies as well as on the crystal morphology and therefore obtain more
precise diagnosis.
© 2015 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ollege de France, 11,
nce.
zin).
ed by Elsevier Masson SAS.1. Introduction
In September 2009, a 64-year-old womanwas admitted
to Necker hospital for rapidly progressive renal insufﬁ-
ciency failure with a serum creatinine increased aroundThis is an open access article under the CC BY-NC-ND license (http://
D. Bazin et al. / C. R. Chimie 19 (2016) 1439e14501440500 mmol/l giving an estimated glomerular ﬁltration rate of
10 ml/min/1.73 m2, which corresponds to a severe
impairment of kidney function (normal value >90 ml/mn/
1.73 m2). Her past medical history revealed well controlled
hypertension diagnosed 10 years ago, and chronic renal
failure diagnosed 2 years ago with a serum creatinine of
215 mmol/l, initially attributed to nephroangiosclerosis
(Fig. 1a). Because no obvious cause for her rapid worsening
of her renal failure was found, a kidney biopsy was per-
formed, showing an extensive tubulo-interstitial ﬁbrosis
scattered with multiple small crystals.
The initial clinical diagnosis suggested adapting the
analyses to a search for the presence of 2,8-
dihydroxyadenine (DHAd), a compound produced by the
body when it is unable to recycle adenine, a molecule that
plays a vital role in human beings [1e6]. Recent data sug-
gest this disease could be less rare than commonly reported
[7]. For this patient, very small size crystals were observed
through optical microscopy and techniques at the hospital
were deﬁnitely not able to determine their chemical nature
(Fig. 1b). Another way is to perform a genetic study. Such
investigation is quite long and expensive. To attain this
goal, we selected mFourier Transform Infrared (FT-IR)
spectroscopy and ﬁnally went to the SMIS (SMIS stands for
Spectroscopy and Microscopy in the Infrared region using
Synchrotron) beamline located at the Synchrotron Radia-
tion national center, namely SOLEIL (Source Optimisee de
Lumiere d'Energie Intermediaire du LURE)-Synchrotron to
perform such an experiment. Quickly, the presence of
DHAd crystals has been identiﬁed in the kidney biopsy. This
early diagnosis made all the difference. The medical treat-
ment (now allopurinol or febuxostat) of the disease thus
identiﬁed is available and was applied at once. The kidney
function of the patient ﬁnally recovered and this patientFig. 1. (a) Evolution of the kidney function as given by the serum creatinine.
The medical diagnosis from crystals in the kidney biopsy cannot be per-
formed at the hospital (in a short time). As we can see the FTIR measure-
ments performed on the SMIS beamline of the Soleil synchrotron radiation
center allow us to identify unambiguously the crystals and allow the clini-
cian to give the right treatment and ﬁnally the serum creatinine decreased
signiﬁcantly avoiding dialysis and a kidney graft for the patient. (b)
Abnormal deposits observed in the tubular cells and interstitium.avoided dialysis processes as well as the kidney trans-
plantation. This clinical case has been reported on different
websites [8] and published [9]. Since this experiment, such
an approach has been performed for seven other patients.
Now, we have started a larger survey on grafted patients
(more than 300 patients are engaged in this investigation),
such experiments being performed either at the Tenon
hospital or at the LCMCPeUPMC on a last generation mFTIR
spectrophotometer [10]. The complete set of results brings
invaluable information to the clinician regarding the rela-
tionship between the presence of deposits and the kidney
function. More precisely, we point out a chemical diversity
regarding the ectopic calciﬁcations present in kidney bi-
opsies and the fact that in a signiﬁcant number of cases,
several chemical compounds can be identiﬁed on the very
same kidney biopsy [10,11]. For kidney biopsies which
display submicrometer crystals, we have developed other
kinds of experiments (see the contribution of M.
Refregiers).
Of note, irrespective of the human cost, the ﬁnancial
cost of an undiagnosed case leading to ESRF (End Stage
Renal Failure) is at least 85 kV per year for dialysis (the
average time before kidney transplantation is about 18e24
months), 85 kV for the kidney graft (around 3100 kidney
transplantations per year in France, that means
3100 85 kV, not far than the price of SOLEIL synchrotron)
and ﬁnally 10 kV per year of medical therapy, management
of side effects and follow-up of the patient. By comparison,
the cost of 8 h synchrotron to establish a clinically relevant
diagnosis is 4 kV (half hour is in fact sufﬁcient) while the
price of a last generation in lab mFTIR spectrometer is
around 100 kV and the cost of an analysis on this equip-
ment is around 160V.
More generally, acute renal failure (ARF), which can be
induced by a wide range of pathophysiological events, is
deﬁned in general terms as an abrupt decrease in renal
function leading to retention of nitrogenous waste and
disruption of ﬂuid and electrolyte homeostasis [12,13]. An
increased body of evidence suggests that crystal formation
plays an important role in acute kidney injury and most
likely also in the development of chronic kidney disease
[14e18]. We have demonstrated that a thorough chemical
analysis of the pathological calciﬁcations present in kidney
biopsies constitutes a major opportunity for indirect diag-
nosis of genetic diseases as well as a signiﬁcant axis of
research [9,11,19e22].
Methods used in the hospital setting to gather infor-
mation on pathological calciﬁcations in biopsies are based
on staining procedures [23,24]. Different publications un-
derline some major limitations of such procedures for the
characterization of ectopic calciﬁcations [25] and staining
procedures such as von Kossa staining alone are not sufﬁ-
cient for identifying and quantifying apatite [26]. Such
pitfalls are linked to a signiﬁcant chemical diversity of
pathological calciﬁcations present in kidney biopsy. The
presence of compounds such as amorphous silica, sodium
hydrogen urate, methyl-1 uric acid and four different Ca
phosphates as carbapatite, whitlockite, octacalcium phos-
phate and amorphous carbonated calcium phosphate in
samples [9,27] makes such staining procedures clearly
inappropriate.
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combine techniques available at hospitals with chemical
and materials science analytical techniques [28e30] such
as Scanning Electron Microscopy (SEM) [31e40], Micro-
Computerized Tomography [41e43], mFTIR and Raman
spectroscopies [44e51], NMR [52e59], ﬂuorescence
induced by X-ray [60e65] or protons [66e70], Mass Spec-
trometry [71e73], ion chromatography [74], Laser capture
microdissection coupledwith label-freemass spectrometry
[75], X-ray or neutron scattering [76e83] or X-ray absorp-
tion spectroscopy [84e96]. It is quite clear that character-
ization techniques speciﬁc to large scale instruments
developed to describe at the atomic scale nanometer scale
materials can be very useful [97e103]. These character-
ization techniques can be completed by a modelization of
the pathogenesis of these calciﬁcations [104e111].
In this report, we ﬁrst address the possibility of coupling
different classical observations on the very same kidney
biopsy material through Field emission scanning electron
microscopy (FE-SEM) experiments combined with energy
dispersive spectroscopy as well as measurements through
Raman and mFTIR spectroscopy. Then, on the same sample,
observations using cutting edge technologies such Syn-
chrotron Radiation (SR) e FTIR or SR-UV visible spectros-
copy could be performed when ectopic calciﬁcations are
made of microcrystals. The complete set of observations
will help the clinician gather information regarding the
nature and the spatial distribution at the subcellular scale
of different chemical phases present in the kidney biopsy
material as well as the morphology of the crystal.
2. Materials and methods
A set of six kidney biopsy samples was investigated. The
biopsies were performed at Tenon Hospital (Paris, France).
Five-micron slices of the tissue samples were deposited on
low-e microscope slides (MirrIR, Kevley Technologies,
Tienta Sciences, Indianapolis). For tissue embedded in
parafﬁn, the parafﬁn was chemically removed with xylene
in order to improve crystal detection under themicroscope.
Each sample was identiﬁed by a study number and ano-
nymized. The ethical committee of Tenon Hospital had
approved the patient consent procedure.
Raman micro-spectroscopy data were recorded on a
DXR Raman microprobe (ThermoScientiﬁc, Courtaboeuf,
France) equipped with a CCD detector. A 10 mW, 532 nm
laser was used for excitation and was focused on the
sample by using a 100/0.8NA objective giving a spot size
of 0.7 mm. The spectra were collected between 100 and
3500 cm1 using low resolution grating and a 25 mm slit,
giving a spectral resolution of 2e4 cm1. Spectra were
collected at 5 mm interval in X and Y with 2 accumulations
of 5 s. Data analysis of Raman spectra and chemical images
was performed using OMNIC software (Thermo Scientiﬁc).
The UV Visible imaging system is built around a Zeiss
Axio Observer (Carl Zeiss, Fr) inverted microscope con-
structed with quartz-only optics. The white beam of the
DISCO beamline at Synchrotron SOLEIL [112] is mono-
chromatised by using an iHR320 (Jobin-Yvon Horiba,
Longjumeau, France) before coupling with the entrance of a
modiﬁed Zeiss Axio Observer Z1 (Carl Zeiss, Germany). Asharp dichroic mirror transmitting only above 300 nm
(Omega Optical, Brattleboro, Vermont) reﬂected the inci-
dent light that is further focused onto the sample through a
Zeiss Ultraﬂuar 40 objective (N.A. 0.65, glycerin imm)
[113,114]. Fluorescence images were recorded with a
Princeton Pixis 1024-BUV (Princeton Instruments, USA)
camera after selection through a series of bandpass ﬁlters
(Semrock, Rochester, USA). Fluorescence images were
typically recorded in 10 s exposure. The whole system is
controlled via mManager software [115].
A Zeiss SUPRA55-VP SEM was used for observation of
the microstructure. This ﬁeld-emission “gun” microscope
(FE-SEM) operates at 0.5e30 kV. High-resolution observa-
tions were obtained by using 2 secondary electron de-
tectors: an in-lens SE detector and an EverharteThornley
SE detector. Measurements were taken at low voltage
(between 0.5 and 2 kV) without the usual deposits of car-
bon at the surface of the sample (Fig. 2a). Energy Dispersive
X-ray (EDX) experiments can also be performed. In order to
perform Ca cartography, the FE-SEM operated at 12 kV.
To obtain Density Dependent Electron Micrographs
(DDC-SEM), [116] samples were coated with carbon and
imaged with a secondary in-lens detector and with a
backscattering detector at 10 kV.
SR IR micro-spectroscopy was performed at the SMIS
beamline (Fig. 2b) at the SOLEIL Synchrotron Radiation
Facility (Saint-Aubin, France) operating at 2.75 GeV with a
current of 430 mA delivered in top-up mode. Details of the
experimental procedure have already been described [117].
IR photons are created by the electrons deﬂected from a
bendingmagnet in the storage ring. The IR photon source is
coupled to a ThermoScientiﬁc Nicolet 5700 FTIR spec-
trometer. Attached to the spectrometer is a CONTINUUMXL
microscope (ThermoScientiﬁc, Courtaboeuf, France). The
detector of the IR microscope is a liquid nitrogen-cooled
mercuryecadmiumetelluride (MCT-A) detector (50 mm).
The microscope was operated in confocal mode, using a
32 inﬁnity corrected Schwarzschild objective (NA ¼ 0.65)
and a matching 32 condenser. All spectra were obtained
using a double-path single-masking aperture (confocal
arrangement), size set to 10 mm  10 mm. The spectra were
collected in trans-reﬂection mode on the low-e slides, in
the 4000e800 cm1 mid-IR range at a resolution of 8 cm1
with 16 co-added scans. Each spectrum was recorded in
approximately 10 s.
IR micro-spectroscopy was also performed on an
IN10MXmicroscope (Thermo Scientiﬁc) for recording large
maps. All spectra were collected in ultrafast mode using a
50 mm  50 mm aperture. The spectra were collected in the
4000e800 cm1 mid-IR range at a resolution of 16 cm1
with one spectrum per pixel. Data analysis of IR spectra and
chemical images was performed using OMNIC software
(Thermo Scientiﬁc) [118,119].
Before discussing the results of our experiments, it is
important to examine the spectral contribution of the low-
e support (without sample) through EDX spectroscopy. This
experiment has been reported in Fig. 2c, which shows the
X-ray ﬂuorescence spectra induced by electrons in the
presence of different trace elements on the support, such as
Zn, Ca, Ag, Si and Mg. Special attention has to be paid to
these elements when they are detected. We will see that in
Fig. 2. The very sample kidney biopsy sample can be positioned either in the FE-SEM (a) or in the SMIS beamline (b). EDX spectrum of the support (c) imaged
with secondary electron detectors (d) showing an homogeneous spatial repartition of Ca on the support as measured by EDX.
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far more important than the Ca of the low-e support. It is
thus possible to build different maps giving the spatial
contribution of Ca. Also, the contribution of Ca present in
the support is homogeneous (Fig. 2d).3. Results and discussion
Characterization of kidney biopsy samples has to take
into account two major speciﬁcities. The fact that such a
sample is precious and that bleeding complications may
follow the biopsy procedure (the percentage of patients
that suffer severe complications after a kidney biopsy is less
than 0.1) [120,121]. Moreover, such a kidney sample may
contain ectopic calciﬁcations constituted of fragile, organic
or inorganic, micrometer-sized crystals. Therefore, mFTIR
spectroscopy is to be selected ﬁrst since it is a non-
destructive technique. It offers the opportunity to charac-
terize the crystals and to evaluate the surface coverage by
the crystals. However, in few cases of very small organic
crystals, for which the signal to noise ratio might be not
enough to accurately determine the chemical composition,
SR-mFTIR experiments can be performed. In the case of
inorganic crystals, Raman experiments make it possible to
characterize kidney biopsy tissue deposited on a classical
hospital support (made of glass, which would beinadequate for FTIR) or evaluate surface coverage by using
whewellite crystals (which can be related to the loss of
kidney function).
Moreover, as underlined by numerous investigations
performed on kidney stones, the crystal morphology could
be relevant and must be assessed by scanning electron
microscopy. Primary hyperoxaluria and eating disorders
are pathologies associated with kidney stones made of the
very same chemical phase, whewellite, but they can be
distinguished through crystal morphology [122e124].
Thus, any possible modiﬁcation of the morphology of
inorganic crystals induced by Raman spectroscopy
(because heating under the laser beam)must be considered
and highlights the importance to well deﬁne the order of
using the various physical methods. We would like now to
discuss these different tools through the characterization of
a set of six kidney biopsies.3.1. The case of organic crystals
Some kidney diseases lead to the formation of organic
crystals. This is the case for cystinuria which is caused by a
mutation in renal epithelial cell transporters and leads to
the formation of cystine kidney stones [17,83,125e133].
Adenine phosphoribosyltransferase deﬁciency is another
rare inherited disorder responsible for the formation of
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rent kidney stones and/or kidney failure [7,134]. This dis-
ease is often underdiagnosed even after conventional
analysis of the kidney biopsy. Observations at the macro-
scopic scale (Fig. 3a and b) show a circular morphology. At
higher magniﬁcations, SEM shows a strong similarity be-
tween the morphology of DHAd crystals present in kidney
biopsy (Fig. 3c) and the ones observed in DHAd kidney
stones (Fig. 3d) [135]. In Fig. 3e, a typical FTIR spectrum is
shown in which the different sharp absorption bands spe-
ciﬁc of DHAd crystals are clearly visible at 1446, 979, 795
and 762 cm1.
When the acquisition time for each FTIR spectrum is
ﬁxed to 0.3 s using a IN10MX microscope, large maps can
be collected in quite a short time, quickly producing
chemical mapping of the kidney biopsy sample
(50 mm  50 mm for the spatial resolution) that provides
signiﬁcant information for clinical practice (Fig. 3f, g).
Another case of organic deposits in kidney biopsies is
related to drug-induced nephrotoxicity. Foscarnet, a drug
used against cytomegalovirus infection, was reported as
crystals formed early in the kidney, in glomeruli of patients,
resulting in acute kidney failure [136e139]. In a previous
investigation, we found foscarnet crystals in glomeruli of a
patient together with an accumulation of apatite crystals in
cells of the proximal tubules [9]. In a set of FTIR experi-
ments performed on a biopsy from another patient, weFig. 3. (a, b) Optical micrograph image of the human biopsy (c) SEM image of DH
crystal in kidney stone. (e) Typical FTIR spectra collected on a mFTIR Experiment
distribution of DHAd crystals in the kidney biopsy as given by the maximum of a sp
more crystals than other parts of the biopsy. The red plus-sign indicates the positihave observed the presence of foscarnet not in glomeruli
but in tubules (Fig. 4aec). These FTIR measurements were
complemented by SEM observations to describe more
precisely the morphology of foscarnet crystallites shown in
Fig. 4d. These observations are important because the
localization in tubules rather than in glomeruli may high-
light another mechanism to explain the progressive kidney
failure in this patient.
3.2. The case of inorganic crystals
Despite the presence of Ca on the support (Fig. 2d), it is
possible to obtain valuable information regarding the
presence of Ca in the biopsy. Fig. 5a shows an image of a
kidney biopsy at lowmagniﬁcation (167) inwhich we can
easily identify a glomerulus and different tubules. Calcium
spatial distribution obtained through EDX spectra is given
in Fig. 5b which clearly shows different areas containing
high amounts of calcium pointing out the presence of
ectopic calciﬁcations.
At this point, it is worth mentioning that EDX spec-
troscopy cannot distinguish between whewellite
(CaC2O4$H2O) and weddellite (CaC2O4$2H2O), the two Ca
oxalate phases identiﬁed in kidney stones. Such discrimi-
nation between these two chemical phases is of major
clinical importance, because whewellite is associated with
hyperoxaluria while weddellite is a signature ofA multiple crystallites in a kidney biopsy (d) SEM image obtained of a DHA
al device (f) On the same sample (2a), large optical image and (g) Spatial
eciﬁc absorption band: the yellow areas (and still more for red ones) contain
on of the beam.
Fig. 4. (a) Optical image of a human biopsy. (b) FTIR spectrum of foscarnet collected on a mFTIR experimental device. (c) Spatial distribution of foscarnet obtained
from FTIR spectra obtained using the intensity of the IR absorption band at 970 cm1. (d) SEM image of foscarnet crystals aggregated within a tubule in the biopsy
sample.
Fig. 5. Various images of a biopsy sample (ref. B212) containing whewellite crystals. (a) SEM observations (b) spatial distribution of Ca in biopsy as measured
through EDX. (c) Optical dark ﬁeld image of B212 in the Raman microscope (d) Spatial distribution of whewellite obtained with Raman spectroscopy, (e) typical
Raman spectrum of whewellite (1460 cm1, 1488 cm1, 1628 cm1, 895 cm1). (f, g) SEM observations before (f) and after (g) RAMAN observations: in red circles
we can see clearly some alterations induced by the laser beam. (h, i, j) mFTIR measurements: (h) optical image (i) whewellite distribution and (j) typical IR
absorption spectrum (peaks at 1315 and 780 cm1) obtained using last generation in lab mFTIR.
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in kidney tissue in the case of heavy hyperoxaluria [142]. It
is quite difﬁcult to distinguish between whewellite and
weddellite crystallites through FE-SEM mainly because
these two chemical phases are associated with various
morphologies. Moreover, due to experimental conditions
(FE-SEM observations are performed under high vacuum),
vibrational spectroscopies such as mFTIR or Raman consti-
tute more efﬁcient techniques.
It is well established that the contributions of whe-
wellite and weddellite in FTIR and Raman spectra are easily
separated owing to the very different values of the associ-
ated absorption bands. The position of signature bands for
whewellite in FTIR spectroscopy is 1620, 1315, and
780 cm1 (respectively 1460 cm1, 1488 cm1, 1628 cm1
and 895 cm1 for Raman) while for weddellite, FTIR ab-
sorption bands are 1643 cm1 and 1324 cm1 (respectively
1475 cm1 and 909 cm1 for Raman).
Taking into account the small size of the crystallites,
Raman spectroscopy (Fig. 5cee) seems to be even more
effective than FTIR but this technique has several draw-
backs. First, in Raman spectroscopy we have to take into
account the presence of intrinsic autoﬂuorescence back-
ground signals, which are usually a few orders of magni-
tude stronger than those arising from Raman scattering
[143]. The presence of such autoﬂuorescence can be a
strong limitation of this technique to characterize crystals
at the micrometer scale. Second, some patients present
extremely low quantities of ectopic calciﬁcation with
fragile, organic, micrometer-sized crystals; we have already
observed that chemical characterization through Raman
spectroscopy even at very low power induces signiﬁcant
alterations of their morphology and, sometimes, the
destruction of the crystals in the case of very heat-sensitive
species. Because human biopsies must be archived for pa-
tient follow-up/quality control, mFTIR spectroscopy, being
non-destructive, is preferable to Raman spectroscopy to
characterize kidney biopsy samples. Finally, even in the
case of ectopic calciﬁcations made of whewellite micro-
crystals, Raman spectroscopy can induce signiﬁcant modi-
ﬁcations (Fig. 5f and g) [144].
All these considerations suggest that classical mFTIR
spectroscopy is a more effective technique to determine the
chemical nature of ectopic calciﬁcations (Fig. 5hej). Last
generation mFTIR spectroscopes are able to collect signiﬁ-
cant data even with a beam size of 10 mm.
Recently, we have underlined that signiﬁcant break-
throughs can been made when cutting edge character-
ization techniques are used. We performed mSR-FTIR
spectroscopy experiments to underline the chemical di-
versity of ectopic calciﬁcations in kidney biopsies and to
propose such techniques as an early diagnostic tool. The
comparison of synchrotron and thermal (globar) source
has been addressed elsewhere [145]. For the character-
ization of micrometer scale crystals present in biological
tissues, there is not really a gap between last generation
in lab experimental device and S.R. beamlines. Never-
theless, in some cases, crystals in tissues may be very
small and classical FTIR microscopy may not be sensitive
enough to identify their chemical composition. mSR-FTIR
is a good alternative technique as it is able to collectvibrational spectra on these microscopic-sized minerals
non-destructively. One limitation of these techniques is
the fact that mFTIR analysis is based on reﬂectance, thus
resulting in the loss of a fraction of the reﬂected beam to
be collected by the detector because the samples are
rarely perfectly ﬂat. Another way to improve sensitivity of
the measurement is to perform an ATR analysis which
offers the opportunity to improve the collected signal
from the sample. In return, this technique is locally
destructive.
Starting with characterization through FTIR spectros-
copy (Fig. 6a and b), additional information can be provided
by DUV imaging of the same sample (Fig. 6c). The recon-
structed image shows the ﬂuorescence between 327 and
353 nm (blue), 370e410 nm (green) and 535e607 nm after
275 nm excitation (scale bar ¼ 50 microns). The red
channel corresponds to lipofuscin vesicles produced after
tissular disorders, the blue channel may be related to pro-
tein accumulations, while the green channel shows
constitutive tissues. A 3D reconstruction of the ﬂuores-
cence induced by DUV synchrotron radiation of a crystal in
a biopsy (Fig. 6c) is also available. When excited at 275 nm,
the crystal presents a bright ﬂuorescence at 580 nm, while
the tissue shows mostly UV ﬂuorescence.
Finally, through scanning electron micrograph and
density-dependent color scanning electron micrographs
(DDC-SEM), we have investigated a kidney biopsy. The
orange color identiﬁes a denser material; structures that
appear green are less dense. These preliminary observa-
tions seem to show that two structures exist. At this point,
we have different possibilities either organic at the surface
and whewellite at the core or amorphous whewellite [146]
at the surface and whewellite at the core (Fig. 6dei). SEM
studies have previously conﬁrmed the distinct structure of
the various types of whewellite crystallite stones at the
mesoscopic scale, as identiﬁed by macroscopic morpho-
logical examination. One of the striking points of this
previous paper dedicated to kidney stones related to the
fact that the morphology of whewellite crystallites is
deﬁned by the pathology. The peculiar morphology of the
type Ic stones appears to be speciﬁc to genetic hyper-
oxaluria, which is thus steering the diagnosis towards a
search for primary hyperoxaluria quite far from the ob-
servations made in the case of intermittent hyperoxaluria
of dietary origin (type Ia stones, the most common). It
seems thus that such diversity regarding the ectopic cal-
ciﬁcations made of whewellite exists also in kidney bi-
opsies but we must consider other factors that are able to
modify the morphology of the crystallites such as the
precise location (tubular lumen, cells or interstitium)
where the crystals may be formed or aggregated. Indeed,
at the microscopic scale, we observe clear differences be-
tween whewellite or dihydroxyadenine crystallite mor-
phologies not yet well understood (Fig. 7). It was
suggested that osteopontin may be an important factor
inﬂuencing crystal appearance in the tissue [134,147].
Other factors and pathological conditions probably may
also exert a signiﬁcant inﬂuence on the crystal
morphology.
Work is in progress to establish a possible relationship
between the morphology of Ca oxalate crystallites in
Fig. 6. (a) Whewellite distribution and (b) optical image obtained on the SMIS beamline of Soleil synchrotron. (c) Reconstructed 3D-RGB image obtained using
Deep UV data collected on the DISCO beamline (scale 10 mm). (d) Scanning electron micrograph and density-dependent color scanning electron micrographs
(DDC-SEM) of kidney biopsy. Micrographs were colored in post-processing by combing images acquired by secondary and backscatter electron detectors [116].
The orange color identiﬁes denser material; structures that appear green are less dense. These preliminary observations seem to show that two structures exist.
At this point, we may have different possibilities either organic at the surface and whewellite at the core or amorphous whewellite at the surface and whewellite
at the core. (d, e) Lower magniﬁcation. Scale bar ¼ 30 mm. (f, g) Higher magniﬁcation of area presented in d and e. Scale bar ¼ 5 mm. (h, i) Details of the crystals in f
and g. Scale bar ¼ 1 mm.
D. Bazin et al. / C. R. Chimie 19 (2016) 1439e14501446human biopsy and either the pathology and or loss of
kidney function. Note that Ca oxalate stones are observed
also in the case of ingestion of ethylene glycol-containing
solution. Moreover, such description at the sub-
micrometer scale of Ca oxalate crystallites may give infor-
mation regarding the possible internalization process of Ca
oxalate crystals [148], the interaction of these mineral
phases and distal renal tubular cells [149].4. Conclusion
Recent publications have demonstrated that techniques
routinely implemented at hospitals, in the determination of
the chemical nature of micro-calciﬁcations in kidney bi-
opsies, such as staining procedures, have major drawbacks.
Moreover, such techniques are not able to accurately
describe the crystal morphology, a parameter which could
Fig. 7. Different aspects of dihydroxyadenine (a and c) and whewellite (b and d) crystallites in kidney biopsies.
D. Bazin et al. / C. R. Chimie 19 (2016) 1439e1450 1447have important clinical signiﬁcance. To attain these goals,
classical as well as cutting edge characterization techniques
can be used. Our data clearly show that major break-
throughs have been obtained; these techniques are already
used as early diagnosis tools to understand the biochemical
process related to the genesis of pathological calciﬁcation.
More precisely, we assessed the use of FE-SEM-EDX and
micro-spectroscopy techniques such as Raman, conven-
tional and SR-FTIR micro-spectroscopy on human kidney
biopsy samples. Combining conventional FTIR micro-
spectroscopy with FE-SEM-EDX seems to be a more effec-
tive approach. As underlined previously, the use of SR-FTIR
micro-spectroscopy is relevant for crystals smaller than
10 mm. Also, we have shown that scanning electron
micrograph and density-dependent color scanning elec-
tron micrographs (DDC-SEM) of kidney biopsy tissues are
able to describe precisely the structures of whewellite
crystallite ectopic calciﬁcations.
Taken together, all these techniques are already at the
core of an early diagnosis tool kit and may allow clinicians
to collect different kinds of information and to identify
unambiguous crystal deposits involved in kidney dysfunc-
tion. Finally, the latest developments performed in UV
visible micro-spectroscopy show that we are on the verge
of collecting exciting results regarding the spatial distri-
bution of organic compounds at a resolution reaching
150 nm.
The approach which underlined the importance of the
interface between chemistry, physics and medicine[149e157] described here could also largely beneﬁt pa-
thologists working on other diseases. Indeed, pathological
calciﬁcations can be present in different tissues, for
example in cartilage [158e162], prostate [163e168],
vascular system [36,169,170], salivary glands [80] or breast
tumors [171e179]. Of note, characterization techniques
such as FTIR are also used in epidemiologic investigations
[180e182].
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